These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5066301)

  • 1. Legal aspects of regulations pertaining to sale and distribution of analytical standards for drugs of abuse. I.
    Evans JG
    J Chromatogr Sci; 1972 May; 10(5):342-6. PubMed ID: 5066301
    [No Abstract]   [Full Text] [Related]  

  • 2. 3. Drug regulations in Switzerland and their application.
    Hippenmeier F
    Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries].
    Burow W; Lüllmann H
    Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution aspects in the potential misuse of O-T-C preparations.
    Myers MJ
    Am J Pharm Sci Support Public Health; 1970; 142(1):29-36. PubMed ID: 5514095
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of the federal government in the development of narcotic antagonists.
    Green AI
    Adv Biochem Psychopharmacol; 1973; 8(0):576-7. PubMed ID: 4795123
    [No Abstract]   [Full Text] [Related]  

  • 6. Today's dilemma--will drugs work?
    Dowling HF
    J Am Pharm Assoc; 1971 Jun; 11(6):331-3. PubMed ID: 5118797
    [No Abstract]   [Full Text] [Related]  

  • 7. Present attitudes of governmental drug regulatory agencies.
    Noel PR
    Int J Clin Pharmacol; 1973 Apr; 7(2):168-77. PubMed ID: 4731283
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health.
    Gostin LO
    JAMA; 2009 May; 301(19):2036-7. PubMed ID: 19454642
    [No Abstract]   [Full Text] [Related]  

  • 9. Legal and social aspects of drug abuse in historical perspective. Is the drug abuser a patient or a criminal?
    Muuss RE
    Adolescence; 1974; 9(36):495-506. PubMed ID: 4617499
    [No Abstract]   [Full Text] [Related]  

  • 10. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 11. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V; Soloviov A; Olefir A
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug safety through drug legislation].
    Kimbel KH
    Internist (Berl); 1978 Jun; 19(6):326-32. PubMed ID: 352981
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimum acceptable requirements for introduction and marketing of drugs.
    Lasagna L
    Drugs; 1974; 7(6):409-13. PubMed ID: 4422210
    [No Abstract]   [Full Text] [Related]  

  • 15. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 16. Involving the pharmaceutical and biotech communities in medication development for substance abuse.
    Gorodetzky CW; Grudzinskas C
    Pharmacol Ther; 2005 Oct; 108(1):109-18. PubMed ID: 16038981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Responsibility for drug testing and control].
    Büchi J
    Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicolegal aspects of drug testing and systems of institutional review.
    Am J Cardiol; 1974 Oct; 34(4):482-4. PubMed ID: 4606800
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug testing: progress and expectations].
    Aschenbrenner R; Lewandowski G
    Internist (Berl); 1973 Jan; 14(1):1-5. PubMed ID: 4576793
    [No Abstract]   [Full Text] [Related]  

  • 20. QUAD routes out inferior drugs.
    Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.